Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public









Cancel


10 Items
Title  Creator  Group name  Publishing year 
Adherence to French and ESGO Quality Indicators in Ovarian Cancer Surgery: An Ad-Hoc Analysis from the Prospective Multicentric CURSOC Study Alejandra et al. EquipeCTCS 2021-03-30
Impact of time to radiation therapy in adjuvant settings in endometrial carcinoma: A multicentric retrospective study Neron et al. EquipeCTCS 2020-04
[Minimal invasive surgery for early stage cervical cancer. Recommendations from the GINECO surgeon's group] Pomel et al. EquipeCTCS Jul 25, 2019
Tubular and mucinous breast cancer: results of a cohort of 917 patients Roux et al. EquipeCTCS 02/2019
Isolated ipsilateral local recurrence of breast cancer: predictive factors and prognostic impact Houvenaeghel et al. EquipeCTCS Jan 2019
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit de Nonneville et al. EquipeCTCS Jun 2019
Overview of the pathological results and treatment characteristics in the first 1000 patients randomized in the SERC trial: axillary dissection versus no axillary dissection in patients with involved sentinel node Others investigators (SERC trial group) et al. EquipeCTCS 12/2018
Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB) Houvenaeghel et al. EquipeCTCS Aug 2017
Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort Forissier et al. EquipeCTCS 12 2017
Efficacy and safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Results from the ANTHALYA trial Rouzier et al. EquipeCTCS 01 2017
10 Items


Who are we ?

Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).

U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)

More                                                                                                                 Join us

Contact us

Institut de Recherche en Cancérologie de
Montpellier (U1194) - Campus Val d'Aurelle

208 avenue des Apothicaires
34298 Montpellier cedex 5 FRANCE

 

insermUM1ICM

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés